Skip to content

Cognitive · compound · regulatory review 2026-10-09

Selank

Tuftsin-derived research peptide studied in GABA-related gene expression.

The cited evidence and any approval concern the studied or labeled preparation. Oral, nasal, cosmetic and research-market versions do not inherit product approval or proven efficacy.

Editorial review 2026-10-09. source-curated; clinician review pending.

FDA product
not established
Compounding
not established
Research
investigational
Sport
unknown

What is Selank?

N-acetyl and amidate versions have their own cards. Those changes are not proven matches. Nasal research solutions and freeze-dried vials are different products.

In plain language

Selank is a lab-made stand-in for tuftsin. Russian-language and later papers look at calm and immune ideas. This source set has no FDA-approved Selank drug. Listed seller size here is 10 mg. Match the vial.

What the evidence says

For each trial, check who or what was studied, which preparation was used and what the findings support before comparing it with personal reports about individual experiences or seller listings that describe a product but don’t establish that it works.

Human trial

Selank: active-comparator anxiety study (2008)

62 patients with generalized anxiety disorder or neurasthenia; 30 Selank and 32 medazepam.

Reported findings. Authors reported similar anxiety improvement to medazepam and antiasthenic effects.

Nonresponse. Nonresponse frequency not established in this excerpt.

Harms. Unknown in reviewed excerpt; absence of mention is not safety evidence.

Limits. Small historical active-comparator study without placebo; blinding and long-term safety detail are limited. Findings do not transfer to N-acetyl/amidated analogues.

Preparation: Source preparation; commercial equivalence unverified. Route: Unknown in reviewed excerpt; do not infer.

Read original source ↗

Editorial review 2026-10-09. Clinician review pending.

Regulatory status, dated 2026-10-09

FDA product approval

not established. No US therapeutic product approval is established by this curated source set; other countries and products may differ.

Compounding

not established. Compounded products do not carry FDA product approval; legal eligibility is not established here.

Research

investigational. Preclinical findings do not establish human anxiety-treatment efficacy.

Sport

unknown. Not individually verified; consult the current sport rules. Absence of a listing is not permission.

How long it lasts, how you store it, listed sizes

This entry doesn’t give a duration in hours. No verified formulation-specific human estimate in this source set; no guessed value is supplied.

The chart uses the 10 mg listing. Modified selank cards keep their own sizes.

U-100 math for listed Selank sizes. Each cell is micrograms per syringe mark if you add that much liquid. The table does the same math as the calculator. It does not pick an amount for you.

Micrograms per U-100 unit (100 marks / mL)
Listed vial1 mL liquid2 mL liquid3 mL liquid
10 mg1005033.3

Risks and mix-ups already on the record

  • Safety is incomplete; absence of reports does not establish safety.
  • Unknown or incomplete for research formulations; this is not a clearance for use.
  • Unknown or incomplete; do not infer compatibility with medications or other substances.

People using PepBear often log: Existing clinician-directed records, symptoms and dated health measurements. Record missing data; trends do not demonstrate causation.

Sources

  1. Primary evidence or regulator source · checked 2026-10-09
  2. Selank: active-comparator anxiety study (2008) · checked 2026-10-09
  3. Selank paper (PubMed 18479057) · checked 2026-10-09
  4. Selank paper (PubMed 20931363) · checked 2026-10-09
  5. FDA compounding substances that may present significant safety risks · checked 2026-10-09

Questions people ask

Is Selank approved for anxiety?

This source set shows no US drug approval. Cited papers are not a diagnosis or a prescription.

Should I use the N-acetyl page instead?

Use the card that matches the name on your vial. This calculator is for the selank id. Open the acetylated card when that is the name on the vial.

Related cards

A licensed clinician must interpret the evidence for your situation. This entry provides education, not treatment instructions. Not medical advice. PepBear does not pick a dose, a cycle, or a seller.

Optional merchant comparison

Where to buy Selank

Compare the same identity, formulation and format. Blends, oral products and different variants stay separate. A lower price does not establish product quality or medical suitability.

We earn a commission when you buy through PepStar LLC partner links or codes RICHPEP and PEPBEAR. Merchant listings are separate from the evidence and do not establish product quality or medical suitability.

Other dated listings with incomplete quantity or equivalence verification (1)

Individual listing · equivalence unverified

Selank product listings. Prices exclude unverified shipping and tax.
Price / savingsProduct / quantityTerms / availabilityAction
Price unavailableProduct subtotal. Shipping and tax excluded where unverified.Selank (10MG)AscensionFormulation not verified · format not verifiedQuantity not verified. No total mg or price per mg.Listed in stock

50% repeat-use program confirmed. Item eligibility, code and stacking unverified; no coupon included in this price.

Dates and offer terms

Price verified: not verified. Quantity verified: not verified.

Listing observed: Oct 9, 2026. Confirm availability with the seller.

Item terms verified: not verified. Eligibility: unknown. Stacking: unknown.

50% repeat-use coupon program confirmed Oct 9, 2026. Actual code, item exclusions and stacking need confirmation before checkout.

Shipping: not verified; seller charges excluded. Tax: not verified; excluded.

View product: Selank (10MG) at Ascension (opens new tab)Exact merchant listingPartner customer link (opens new tab)Opens the partner referral page. Choose the exact product there; this is separate from the listing above.
Listing source

listing · Oct 9, 2026